Sequent Asset Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Sequent Asset Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-28,690	Closed	-$1.2M	–	68
2018 Q1	$1.2M	Sell	28,690 -350	-1%	-$15.3K	0.72%	25
2017 Q4	$1.26M	Buy	29,040 +500	+2%	+$21.3K	0.69%	25
2017 Q3	$1.21M	Sell	28,540 -150	-0.5%	-$6.36K	0.71%	23
2017 Q2	$1.24M	Buy	28,690 +10	+0%	+$422	0.75%	23
2017 Q1	$1.2M	Buy	+28,680	New	+$1.17M	0.68%	26
2015 Q4	–	Sell	-9,858	Closed	-$463K	–	71
2015 Q3	$463K	Sell	9,858 -190	-2%	-$11.4K	0.35%	53
2015 Q2	$626K	Buy	+10,048	New	+$626K	0.44%	50

Other funds holding XPH

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JGGDR

JGP Global Gestao de Recursos Rio De Janeiro, Brazil $45.3M AUM 42.75% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sequent Asset Management's XPH Position: Q2 2018 in Review

Sequent Asset Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2018, closing a stake of 28,690 shares — an estimated $1.2M sold.

Sequent Asset Management first reported a position in XPH in Q2 2015 and held it in 7 quarters. The position peaked at $1.26M in Q4 2017. 70 funds tracked by Wall St. Rank hold XPH as of Q2 2018.

Sequent Asset Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
Sequent Asset Management sold 28,690 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2018, an estimated $1.2M.
Sequent Asset Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2015 and held it in 7 quarters.
Sequent Asset Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.26M in Q4 2017.
70 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2018.

Based on Sequent Asset Management's 13F filing for Q2 2018, filed 30 Jul 2018.